Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,988 | 1,068 | 98.9% |
| Education | $199.10 | 9 | 1.0% |
| Consulting Fee | $17.11 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $5,108 | 281 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $2,953 | 162 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,923 | 108 | $0 (2024) |
| Janssen Biotech, Inc. | $1,587 | 78 | $0 (2024) |
| Celgene Corporation | $993.92 | 61 | $0 (2024) |
| RedHill Biopharma Inc. | $651.21 | 35 | $0 (2023) |
| PFIZER INC. | $629.55 | 35 | $0 (2024) |
| Merck Sharp & Dohme LLC | $534.21 | 27 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $490.14 | 24 | $0 (2017) |
| VIVUS LLC | $474.04 | 25 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,420 | 149 | ABBVIE INC. ($944.20) |
| 2023 | $3,070 | 150 | AbbVie Inc. ($909.58) |
| 2022 | $3,332 | 169 | ABBVIE INC. ($894.40) |
| 2021 | $3,218 | 176 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($652.91) |
| 2020 | $1,626 | 95 | AbbVie Inc. ($414.87) |
| 2019 | $1,830 | 108 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($464.83) |
| 2018 | $1,893 | 125 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($516.95) |
| 2017 | $1,814 | 106 | Valeant Pharmaceuticals North America LLC ($490.14) |
All Payment Transactions
1,078 individual payment records from CMS Open Payments — Page 1 of 44
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Gastroenterology | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.98 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $3.12 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/15/2024 | ABBVIE INC. | LINZESS (Drug), VIBERZI, CREON | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $5.30 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $5.72 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Food and Beverage | In-kind items and services | $30.15 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/25/2024 | ABBVIE INC. | CREON (Drug), VIBERZI, LINZESS | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/25/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $0.78 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $31.83 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $3.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $26.49 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $4.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $26.12 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $25.10 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/07/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $121.86 | General |
| Category: LIVER DISEASE | ||||||
| 11/05/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/01/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $30.50 | General |
| Category: Immunology | ||||||
| 10/28/2024 | ABBVIE INC. | LINZESS (Drug), VIBERZI, CREON | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/28/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $32.67 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Food and Beverage | In-kind items and services | $29.03 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.75 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,053 | 1,201 | $571,279 | $115,023 |
| 2022 | 12 | 1,034 | 1,187 | $572,919 | $114,026 |
| 2021 | 12 | 1,034 | 1,176 | $578,875 | $112,564 |
| 2020 | 12 | 852 | 1,012 | $469,298 | $86,766 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 230 | 329 | $89,817 | $30,564 | 34.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 258 | 301 | $55,986 | $19,499 | 34.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 62 | 63 | $69,552 | $12,913 | 18.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 83 | 83 | $34,445 | $10,012 | 29.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 117 | 121 | $108,416 | $8,332 | 7.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 106 | 106 | $28,938 | $8,164 | 28.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 44 | 44 | $35,948 | $7,907 | 22.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 53 | 53 | $55,332 | $5,089 | 9.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 25 | 25 | $20,041 | $3,421 | 17.1% |
| 45384 | Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | Facility | 2023 | 29 | 29 | $33,814 | $3,372 | 10.0% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 21 | 22 | $20,438 | $2,629 | 12.9% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 12 | 12 | $9,816 | $2,200 | 22.4% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 13 | 13 | $8,736 | $922.36 | 10.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 222 | 316 | $86,978 | $30,146 | 34.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 234 | 287 | $53,556 | $18,380 | 34.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 80 | 80 | $88,320 | $16,375 | 18.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 92 | 92 | $38,180 | $11,315 | 29.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 122 | 127 | $113,792 | $8,015 | 7.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 43 | 43 | $35,131 | $7,696 | 21.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 105 | 105 | $28,665 | $7,693 | 26.8% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 41 | 42 | $39,018 | $5,007 | 12.8% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 27 | 27 | $21,677 | $3,542 | 16.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 31 | 31 | $32,364 | $2,746 | 8.5% |
| 45384 | Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | Facility | 2022 | 21 | 21 | $24,486 | $1,975 | 8.1% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 16 | 16 | $10,752 | $1,136 | 10.6% |
About Dr. Roland Shepard, MD
Dr. Roland Shepard, MD is a Gastroenterology healthcare provider based in Tampa, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1326034885.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Roland Shepard, MD has received a total of $20,204 in payments from pharmaceutical and medical device companies, with $3,420 received in 2024. These payments were reported across 1,078 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($19,988).
As a Medicare-enrolled provider, Shepard has provided services to 3,973 Medicare beneficiaries, totaling 4,576 services with total Medicare billing of $428,380. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Tampa, FL
- Active Since 09/21/2005
- Last Updated 08/27/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1326034885
Products in Payments
- XIFAXAN (Drug) $2,374
- LINZESS (Drug) $1,252
- ENTYVIO (Biological) $1,061
- STELARA (Biological) $1,038
- ZEPOSIA (Drug) $986.57
- RINVOQ (Biological) $864.73
- SKYRIZI (Biological) $864.36
- Humira (Biological) $749.42
- XELJANZ (Drug) $608.14
- Creon (Drug) $572.73
- ZENPEP (Drug) $551.74
- DIFICID (Drug) $534.21
- APRISO (Drug) $479.66
- HUMIRA (Biological) $472.31
- DUPIXENT (Biological) $468.97
- Entyvio (Biological) $387.42
- PANCREAZE (Drug) $374.80
- CREON (Drug) $336.90
- REMICADE (Biological) $307.07
- VIBERZI (Drug) $303.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Tampa
John Jacobs, M.d, M.D
Gastroenterology — Payments: $73,013
Dr. Renee Marchioni Beery, D.o, D.O
Gastroenterology — Payments: $66,910
Dr. Shaffer Mok, M.d, M.D
Gastroenterology — Payments: $35,137
Pushpak Taunk
Gastroenterology — Payments: $25,965
Dr. John Delgado, M.d, M.D
Gastroenterology — Payments: $22,410
Ricardo Prieto, M.d, M.D
Gastroenterology — Payments: $18,202